These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9014204)

  • 1. CYP2C19 genotype and phenotype determined by omeprazole in a Korean population.
    Roh HK; Dahl ML; Tybring G; Yamada H; Cha YN; Bertilsson L
    Pharmacogenetics; 1996 Dec; 6(6):547-51. PubMed ID: 9014204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype.
    Chang M; Dahl ML; Tybring G; Götharson E; Bertilsson L
    Pharmacogenetics; 1995 Dec; 5(6):358-63. PubMed ID: 8747407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype.
    Herrlin K; Massele AY; Jande M; Alm C; Tybring G; Abdi YA; Wennerholm A; Johansson I; Dahl ML; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 1998 Oct; 64(4):391-401. PubMed ID: 9797796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.
    Persson I; Aklillu E; Rodrigues F; Bertilsson L; Ingelman-Sundberg M
    Pharmacogenetics; 1996 Dec; 6(6):521-6. PubMed ID: 9014201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection.
    Sagar M; Seensalu R; Tybring G; Dahl ML; Bertilsson L
    Scand J Gastroenterol; 1998 Oct; 33(10):1034-8. PubMed ID: 9829356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy.
    Kimura M; Ieiri I; Wada Y; Mamiya K; Urae A; Iimori E; Sakai T; Otsubo K; Higuchi S
    Br J Clin Pharmacol; 1999 Jan; 47(1):115-9. PubMed ID: 10073749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
    Ishizawa Y; Yasui-Furukori N; Takahata T; Sasaki M; Tateishi T
    Clin Pharmacokinet; 2005; 44(11):1179-89. PubMed ID: 16231968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
    Wang JH; Li PQ; Fu QY; Li QX; Cai WW
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):421-4. PubMed ID: 17439410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.
    Rosemary J; Adithan C; Padmaja N; Shashindran CH; Gerard N; Krishnamoorthy R
    Eur J Clin Pharmacol; 2005 Mar; 61(1):19-23. PubMed ID: 15662508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.
    He N; Yan FX; Huang SL; Wang W; Xiao ZS; Liu ZQ; Zhou HH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):15-8. PubMed ID: 11956668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.
    Ieiri I; Mamiya K; Urae A; Wada Y; Kimura M; Irie S; Amamoto T; Kubota T; Yoshioka S; Nakamura K; Nakano S; Tashiro N; Higuchi S
    Br J Clin Pharmacol; 1997 Apr; 43(4):441-5. PubMed ID: 9146858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C19 genetic mutations in North Indians.
    Lamba JK; Dhiman RK; Kohli KK
    Clin Pharmacol Ther; 2000 Sep; 68(3):328-35. PubMed ID: 11014415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study.
    Balian JD; Sukhova N; Harris JW; Hewett J; Pickle L; Goldstein JA; Woosley RL; Flockhart DA
    Clin Pharmacol Ther; 1995 Jun; 57(6):662-9. PubMed ID: 7781266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin.
    Zhou Q; Yamamoto I; Fukuda T; Ohno M; Sumida A; Azuma J
    Eur J Clin Pharmacol; 1999 Mar; 55(1):43-7. PubMed ID: 10206083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.
    Isaza C; Henao J; Martínez JH; Sepúlveda Arias JC; Beltrán L
    BMC Clin Pharmacol; 2007 Jul; 7():6. PubMed ID: 17623107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.
    Yin OQ; Tomlinson B; Chow AH; Waye MM; Chow MS
    J Clin Pharmacol; 2004 Jun; 44(6):582-9. PubMed ID: 15145965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
    Uno T; Niioka T; Hayakari M; Yasui-Furukori N; Sugawara K; Tateishi T
    Eur J Clin Pharmacol; 2007 Feb; 63(2):143-9. PubMed ID: 17203292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.
    Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects.
    Ieiri I; Kubota T; Urae A; Kimura M; Wada Y; Mamiya K; Yoshioka S; Irie S; Amamoto T; Nakamura K; Nakano S; Higuchi S
    Clin Pharmacol Ther; 1996 Jun; 59(6):647-53. PubMed ID: 8681489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.
    Tassaneeyakul W; Tawalee A; Tassaneeyakul W; Kukongviriyapan V; Blaisdell J; Goldstein JA; Gaysornsiri D
    Pharmacogenetics; 2002 Apr; 12(3):221-5. PubMed ID: 11927837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.